AIRLINK 88.80 Decreased By ▼ -0.90 (-1%)
BOP 4.84 Decreased By ▼ -0.12 (-2.42%)
CNERGY 3.96 Decreased By ▼ -0.07 (-1.74%)
DFML 40.15 Decreased By ▼ -0.41 (-1.01%)
DGKC 90.25 Decreased By ▼ -0.15 (-0.17%)
FCCL 22.99 Decreased By ▼ -0.10 (-0.43%)
FFBL 33.50 Decreased By ▼ -0.80 (-2.33%)
FFL 9.14 Increased By ▲ 0.06 (0.66%)
GGL 9.91 Decreased By ▼ -0.03 (-0.3%)
HASCOL 6.05 Decreased By ▼ -0.04 (-0.66%)
HBL 125.62 Decreased By ▼ -1.37 (-1.08%)
HUBC 163.72 Decreased By ▼ -1.53 (-0.93%)
HUMNL 10.77 Decreased By ▼ -0.06 (-0.55%)
KEL 4.41 Decreased By ▼ -0.11 (-2.43%)
KOSM 4.23 Decreased By ▼ -0.11 (-2.53%)
MLCF 38.00 Increased By ▲ 0.10 (0.26%)
OGDC 128.81 Decreased By ▼ -3.37 (-2.55%)
PAEL 24.85 Decreased By ▼ -0.02 (-0.08%)
PIBTL 6.14 Increased By ▲ 0.06 (0.99%)
PPL 116.66 Decreased By ▼ -1.58 (-1.34%)
PRL 24.15 Decreased By ▼ -0.15 (-0.62%)
PTC 12.00 Decreased By ▼ -0.15 (-1.23%)
SEARL 57.92 Decreased By ▼ -0.53 (-0.91%)
SNGP 64.25 Decreased By ▼ -0.30 (-0.46%)
SSGC 9.66 Decreased By ▼ -0.10 (-1.02%)
TELE 7.60 Decreased By ▼ -0.07 (-0.91%)
TPLP 8.98 Decreased By ▼ -0.20 (-2.18%)
TRG 62.80 Decreased By ▼ -0.60 (-0.95%)
UNITY 29.66 Increased By ▲ 2.49 (9.16%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 8,246 Decreased By -46.1 (-0.56%)
BR30 26,414 Decreased By -199.7 (-0.75%)
KSE100 77,941 Decreased By -291.5 (-0.37%)
KSE30 25,187 Decreased By -117 (-0.46%)
World

WHO says awaits EMA, FDA reviews of J&J COVID-19 vaccine, monitoring global data

  • U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.
Published April 13, 2021 Updated April 14, 2021

GENEVA: The World Health Organization, asked about reports of rare blood clots after vaccination with the Johnson & Johnson COVID-19 shot, told Reuters on Tuesday that it awaited reviews by the U.S. and European regulators and was monitoring global data.

"We're watching closely, waiting for EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) reviews and monitoring the global database of adverse event reports to see if there have been cases anywhere else," the WHO said in an email reply. "It will take a little time to review the data."

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.

Following the news, J&J said it was delaying the rollout of the vaccine to Europe, a week after regulators there said they were reviewing rare blood clots in four recipients of the shot in the United States.

Comments

Comments are closed.